This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-PERMANENT — risk:benefit fails for the canonical archetype.
Trimetazidine
Anti-anginal metabolic modulator (fatty-acid oxidation inhibitor → glucose-oxidation shift).
Aliases (4)
Overview
What is Trimetazidine?
Anti-anginal metabolic modulator (fatty-acid oxidation inhibitor → glucose-oxidation shift). EU/CIS Rx. WADA-banned since 2014 (Kamila Valieva 2022 case). Drug-induced Parkinsonism is the permanent-harm signal.
What to Expect
- Week 1Tolerability and dose-response.
- Week 2-4Early effect window.
- Week 4-8Peak benefit assessment.
- Week 8+Cycle decision point.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.